Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Scientific Reports|October 28, 2015
Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled TrialsQin Li, Han Yan, Pengfei Zhao, et al.
Bioscience, Biotechnology, and Biochemistry|January 1, 2020
Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapyYingjie Ma, Junxian Yu, Qin Li, et al.
Toxicology Letters|February 14, 2013
Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathwayJing Yu, Xiaoyun Zhu, Xin Qi, et al.
BMC Immunology|January 24, 2024
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitorsJingting Wang, Yan Ma, Haishan Lin, et al.
International Immunopharmacology|April 30, 2024
Association of pathological response with long-term survival outcomes after neoadjuvant immunotherapy: A meta-analysisChenyu Wei, Haolin Sun, Jiexuan Hu, et al.
Oncology Letters|June 22, 2018
The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cellsHuihui Li, Yichang Fan, Fan Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 26, 2021
Tumor-Associated Macrophage-Derived Exosomes Promote the Progression of Gastric Cancer by Regulating the P38MAPK Signaling Pathway and the Immune Checkpoint PD-L1Yusheng Wang, Kun Shang, Ninggang Zhang, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2023
Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literatureYan Kang, Hongchao Zhen, Nina Ma, et al.
International Journal of Molecular Medicine|August 4, 2023
METTL14‑mediated RNA methylation in digestive system tumorsJiexuan Hu, Haishan Lin, Cong Wang, et al.
Nutrition and Cancer|February 1, 2022
The Prognostic Value of Albumin-Globulin Ratio and Eosinophil-Neutrophil Ratio in Patients with Advanced Tumors Undergoing Treatment with PD-1/PD-L1 InhibitorsYan Ma, Kun Shang, Shanshan Wu, et al.
Pageof 11